Janus Henderson Group PLC Verona Pharma PLC Transaction History
Janus Henderson Group PLC
- $182 Billion
- Q2 2024
A detailed history of Janus Henderson Group PLC transactions in Verona Pharma PLC stock. As of the latest transaction made, Janus Henderson Group PLC holds 1,092,042 shares of VRNA stock, worth $43.5 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,092,042
Previous 2,031,994
46.26%
Holding current value
$43.5 Million
Previous $32.7 Million
51.7%
% of portfolio
0.01%
Previous 0.02%
Shares
8 transactions
Others Institutions Holding VRNA
# of Institutions
150Shares Held
66.3MCall Options Held
495KPut Options Held
486K-
Ra Capital Management, L.P. Boston, MA7.63MShares$304 Million1.66% of portfolio
-
Nea Management Company, LLC Timonium, MD5.58MShares$223 Million7.62% of portfolio
-
Deep Track Capital, LP Greenwich, CT4MShares$159 Million1.9% of portfolio
-
Vivo Capital, LLC Palo Alto, CA3.55MShares$142 Million7.58% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.31MShares$132 Million2.82% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $2.43B
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...